The Ultimate Growth Stock to Buy With $500 Right Now

Up 62% in the last year, Well Health Technologies is a growth stock that’s looking forward to more strong growth and returns.

| More on:
telehealth stocks

Image source: Getty Images

Growth stocks offer investors the potential to make life-changing returns. While they usually carry higher risk than the safer, more established stocks, including them in a well-diversified portfolio is essential.

In this article, I will discuss Well Health Technologies Corp. (TSX:WELL), one of the best growth stocks to buy today.

Digitizing the healthcare industry

Well Health is bringing technology to the healthcare industry.

I think we have all had slow, inefficient, and painstaking experiences with healthcare. Whether it’s long wait times at our appointments, or difficulties connecting with healthcare practitioners, Well Health aims to solve these problems.

And it is, in fact, doing so. Shorter wait times, improved access to physicians, and access to results are all improving the patient experience as well as patient outcomes. But it doesn’t end there. The benefits are clear for the physicians too, as they are able to focus more on care, rather than get bogged down by administrative tasks and running the business. This is leading to less burnout, greater efficiencies, and more empowered patients. It’s clearly a win-win scenario.

Well Health is profiting from strong growth

We can clearly understand why healthcare providers are seeking out Well Health’s digital solutions. And this is evident in Well Health’s results.

In its latest quarter (Q3 2024), Well Health reported its 23rd consecutive quarter of record-breaking results. Revenue increased 27% to $251.7 million. Also, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 16% to $32.7 million.

Furthermore, the company is achieving really strong returns. For example, Well Health’s return on invested capital (ROIC) for all clinics acquired in 2022, 2023, and 2024 was  41%, 24%, and 28% respectively. Also, the company’s margins are increasing at a solid rate.

So, we can see that Well Health stock offers not only strong growth but also strong and increasing returns. And Well Health’s stock price has been increasingly reflecting this positive and exciting reality. As you can see from the graph below, Well Health’s stock price has increased 62% in the last year and over 200% in the last five years.

Here’s why I think the momentum in this growth stock’s price will continue and why I think it’s one of the best stocks to buy now.

The market remains untapped

The primary care market in Canada remains a very large and pretty much untapped market. In fact, of the $40 billion of physician spending, Well Health has roughly $400 million. This means that there is still plenty of opportunity for growth.

Currently, the company’s mergers and acquisition (M&A) pipeline stands at 165 clinics. These clinics generate more than $440 million of annual revenue at double digit margins. Also, the company’s pipeline of signed acquisitions stands at 19 clinics, which represents $50 million in revenue at double digit margins.

The three-year average ROIC of Well Health’s acquisitions is 30%. Clearly, the company is generating strong returns and value-added for both physicians and its shareholders.

The bottom line

In summary, Well Health’s growth has only just begun, which makes it a top stock to buy. With its history of strong execution and operational excellence, the company has shown that it can deliver. All of this is captured in Well Health’s earnings estimates.

For 2024, analysts are expecting earnings per share (EPS) of $0.20, and by 2027, they’re expecting EPS of $0.31. This compares to break-even earnings in 2023 and 2022 and losses in the prior years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Stethoscope with dollar shaped cord
Tech Stocks

Buy the Dip in This TSX Healthcare Stock Right Now

Down 30% from all-time highs, Andlauer Healthcare is a TSX stock that trades at a discount to consensus price targets.

Read more »

hand stacks coins
Dividend Stocks

Key Canadian Dividend Stocks to Compound Wealth Over 2025

These three Canadian dividend stocks could help investors in building wealth.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Dividend Stocks

The Best Canadian Dividend Stocks to Buy and Hold Forever in a TFSA

TFSA investors can avoid the need to fly to safety during market turns by owning the best Canadian dividend stocks.

Read more »

Dividend Stocks

Buy the Dip: Why This TSX REIT Is a Hidden Gem Right Now

Want a great price, a stable business, and potential growth? Oh, plus a nice dividend? Then this REIT is for…

Read more »

Safety helmets and gloves hang from a rack on a mining site.
Dividend Stocks

Down 32% From Highs: Is It Time to Load Up on This Growth Stock?

This growth stock neared double digits earlier this year, so what happened to make it drop 32%?

Read more »

chip with the letters "AI" on it
Tech Stocks

1 TSX Stock That Could Triple by 2026

A TSX stock and winning investment last year could triple in value by 2026.

Read more »

Investor reading the newspaper
Investing

Future-Proof Your Wealth: 3 TSX Stocks for Long-Term Gains

These TSX stocks are poised to deliver solid growth benefitting from long-term growth trends and their favourable market positioning.

Read more »

sale discount best price
Stocks for Beginners

Plummet Alert! This Top Canadian Stock is Still Down 29% – Should You Buy?

Aritzia stock might be down 29%, but has already improved from 52-week lows. So where does that leave investors?

Read more »